Acetic Acid

Acetic Acid

SCHEMBL2861217

CC(=O)O.N#CC1CCCCC1

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.36
MAPK10 P53779 1/20 0.35
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
HSD11B1 P28845 1/20 0.33
FFAR3 O14843 1/20 0.33
LCK P06239 1/20 0.33
FYN P06241 1/20 0.33
DPP4 P27487 4/20 0.32
DPP8 Q6V1X1 1/20 0.32
DPP7 Q9UHL4 1/20 0.32
EPHX1 P07099 5/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
CTSK P43235 2/20 0.31
MAPT P10636 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL10618281 0.90 CES2 (0.38) CES2CES1HSD11B1DPP4DPP8
Hydrogen Peroxide SCHEMBL28133733 0.87 CES2 (0.30) CES2CES1
Acetic Acid SCHEMBL9843899 0.86 CA1 (0.39) HPGDMAPK10CES2CES1HSD11B1
Acetic Acid SCHEMBL9843831 0.86 CA1 (0.35) HPGDMAPK10CES2CES1HSD11B1
SCHEMBL10437830 0.83 CES2 (0.36) CES2CES1HSD11B1DPP4DPP8
SCHEMBL24003864 0.82 CES2 (0.42) HPGDCES2CES1HSD11B1DPP4
Acetic Acid Methyl Ester SCHEMBL28239396 0.82 ALDH1A1 (0.43) HPGDMAPK10HSD11B1DPP4DPP8
Maleic Acid SCHEMBL6838884 0.82 HTT (0.47) CES2CES1DPP4DPP8DPP7
Ethane SCHEMBL2154402 0.82 KCNH2 (0.30)
SCHEMBL28037497 0.82 CES2 (0.30) CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0414262-B1 Process for the preparation of cyclic amino anticonvulsant compounds WARNER LAMBERT CO (US) 1994-11-30 EP claimed
CN-117835831-A Flavor modulating composition 玉米产品开发公司 2024-04-05 CN disclosed
CN-116143644-A Method for continuously preparing gabapentin 浙江华海药业股份有限公司 2023-05-23 CN disclosed
WO-2019157921-A1 NITRILASE MUTANT AND APPLICATION THEREOF 浙江工业大学 2019-08-22 WO disclosed
CN-104911225-A Method for preparing gabapentin with chemo-enzymatic method UNIV ZHEJIANG TECHNOLOGY 2015-09-16 CN disclosed
CN-104911174-A Immobilization method for cells containing nitrilase UNIV ZHEJIANG TECHNOLOGY 2015-09-16 CN disclosed
CN-101484413-B Process for preparing gabapentin ZACH SYSTEM SPA 2014-05-14 CN disclosed
EP-1603863-B1 PROCESS FOR THE PREPARATION OF AMINO METHYL CYCLO ALKANE ACETIC ACIDS HIKAL LTD (IN) 2010-01-13 EP disclosed
JP-2007297386-A METHOD FOR PREPARING GABAPENTIN PFIZER SCIENCE & TECHNOLOGY IRELAND LTD 2007-11-15 JP disclosed
EP-0414262-A2 Process for the preparation of cyclic amino anticonvulsant compounds WARNER-LAMBERT COMPANY (US) 1991-02-27 EP disclosed